Human Prostate Tissue MicroArray (Cancer) from Novus Biologicals, a Bio-Techne Brand

Product Specs
ItemHuman Prostate Tissue MicroArray (Cancer)
CompanyNovus Biologicals, a Bio-Techne Brand
Price $269.00Supplier Page View Company Product Page
Catalog NumberNBP2-30169
Quantity1 Slide
ApplicationsImmunohistochemistry, Immunohistochemistry-Paraffin, Hematoxylin and Eosin Stain
TypeTissue Microarrays
StorageStore at 4C. Do not freeze
SpeciesHuman

Add to Compare List

Novus Biologicals, a Bio-Techne Brand

United States: 10771 E Easter Ave

Centennial, Colorado 80112

United States

Phone:
303-730-1950
888-506-6887

Email: novus@novusbio.com

Company Profile

Website: https://www.novusbio.com

(1) Safe immunosuppression-resistant pan-cancer immunotherapeutics by velcro-like density-dependent targeting of tumor-associated carbohydrate antigensCellNovember 26, 2025Zhou RW, Purohit PK, Kim JH, Lee SU, Burshteyn N, Tifrea D, Cordon A, Grigorian A, Newton BL, Edwards RA, et al.microarrays from US Biomax (FDA999u, FDA999w and BR1005b), US Biolabs (FDA999-1), Novus Biologicals (NBP2-30169) and mouse (C57BL/6) tissue microarray from Pantomics (AMS545) were stained with L-PHA-biotin (0.25

(2) The cancer testis antigen TDRD1 regulates prostate cancer proliferation by associating with snRNP biogenesis machineryResearch squareFebruary 22, 2023Feng Q, Kim H, Barua A, Huang L, Bolaji M, Zachariah S, Jung SY, He B, Zhou T, Mitra A.on the prostate cancer tissue microarray, which was commercially available from Novus Biologicals (NBP2-30169) (Centennial, CO, USA). Statistics Data in this study were analyzed using Prizm 8.0 (GraphPad, San

(3) Jumonji domain-containing protein RIOX2 is overexpressed and associated with worse survival outcomes in prostate cancersFrontiers in oncologyJanuary 1, 2023He C, Liu W, Sun J, Zhang D, Li B.

(4) Fluid shear stress facilitates prostate cancer metastasis through Piezo1-Src-YAP axisLife sciencesNovember 1, 2022Kim OH, Choi YW, Park JH, Hong SA, Hong M, Chang IH, Lee HJ.

(5) A basal-enriched microRNA is required for prostate tumorigenesis in a Pten knockout mouse modelMolecular carcinogenesisDecember 1, 2019Fan X, Bjerke GA, Riemondy K, Wang L, Yi R.Representative images are shown in the figures. Human tissue array slides were purchased from Novus (#NBP2-30169), detailed information could be found: http://www.novusbio.com/Prostate-cancer-tissue-Tissue-Micro-Array_NBP2-30169.html#dsTab0 2.6

(6) Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissuePloS oneJanuary 1, 2015Jones AC, Antillon KS, Jenkins SM, Janos SN, Overton HN, Shoshan DS, Fischer EG, Trujillo KA, Bisoffi M.normal tissues matched to their corresponding tumors was purchased from Novus Biologicals (catalog #NBP2–30169; San Diego CA). The mean age of the tissue microarray cases was 64.2 years with a range of 44–70 years.

(7) Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasisThe Journal of clinical investigationJuly 1, 2014Wu JB, Shao C, Li X, Li Q, Hu P, Shi C, Li Y, Chen YT, Yin F, Liao CP, et al.

(8) Myeloid-specific expression of Ron receptor kinase promotes prostate tumor growthCancer researchMarch 15, 2013Gurusamy D, Gray JK, Pathrose P, Kulkarni RM, Finkleman FD, Waltz SE.

(9) Expression of the stress response oncoprotein LEDGF/p75 in human cancer: a study of 21 tumor typesPloS oneJanuary 1, 2012Basu A, Rojas H, Banerjee H, Cabrera IB, Perez KY, De León M, Casiano CA.

(10) Targeting tyrosine phosphorylation of PCNA inhibits prostate cancer growthMolecular cancer therapeuticsJanuary 1, 2011Zhao H, Lo YH, Ma L, Waltz SE, Gray JK, Hung MC, Wang SC.

(11) Nuclear and cytoplasmic accumulation of Ep-ICD is frequently detected in human epithelial cancersPloS oneNovember 30, 2010Ralhan R, He HC, So AK, Tripathi SC, Kumar M, Hasan MR, Kaur J, Kashat L, MacMillan C, Chauhan SS, et al.

(12) Coordinate suppression of Sdpr and Fhl1 expression in tumors of the breast, kidney, and prostateCancer scienceJuly 1, 2008Li X, Jia Z, Shen Y, Ichikawa H, Jarvik J, Nagele RG, Goldberg GS.

(13) Rad9 has a functional role in human prostate carcinogenesisCancer researchMarch 1, 2008Zhu A, Zhang CX, Lieberman HB.

(14) Loss of mir-146a function in hormone-refractory prostate cancerRNA (New York, N.Y.)March 1, 2008Lin SL, Chiang A, Chang D, Ying SY.

(15) Constitutively activated Stat3 induces tumorigenesis and enhances cell motility of prostate epithelial cells through integrin beta 6Molecular and cellular biologyJune 1, 2007Azare J, Leslie K, Al-Ahmadie H, Gerald W, Weinreb PH, Violette SM, Bromberg J.

(16) Toll like receptor-9 agonists stimulate prostate cancer invasion in vitroThe ProstateMay 15, 2007Ilvesaro JM, Merrell MA, Swain TM, Davidson J, Zayzafoon M, Harris KW, Selander KS.

(17) Impact of differential cyclin D1 expression and localisation in prostate cancerBritish journal of cancerMarch 26, 2007Comstock CE, Revelo MP, Buncher CR, Knudsen KE.

(18) Hyaluronan stimulates transformation of androgen-independent prostate cancerCarcinogenesisFebruary 1, 2007Lin SL, Chang D, Ying SY.

(19) Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family memberCancer researchSeptember 15, 2006O'Toole JM, Rabenau KE, Burns K, Lu D, Mangalampalli V, Balderes P, Covino N, Bassi R, Prewett M, Gottfredsen KJ, et al.

(20) Soluble and transmembrane isoforms of novel interleukin-17 receptor-like protein by RNA splicing and expression in prostate cancerThe Journal of biological chemistryFebruary 8, 2002Haudenschild D, Moseley T, Rose L, Reddi AH.

Be the First to Write a Review!